Literature DB >> 24342155

Radiologically innocuous breast reduction specimens. Should we send them to pathology lab anyway?

B Celik, D Senen Demiroz, M Yaz, U Muslu.   

Abstract

Breast Reduction (BR) is a common procedure around the world. Patients are screened for incidental carcinoma preoperatively by mammography or ultrasonography and BR specimens are sent for pathologic examination postoperatively. Since the incidence of incidental carcinoma is very low, no consensus exist regarding efficiency of pathologic examination. To assess the value of pathologic examination, we examined mammographically and ultrasonographically negative eighty BR specimens from 40 women. Twenty seven women had pathological lesions in their specimens (67,5%). This indicates that, even mammographically and ultrasonographically innocuous, BR specimens may reveal important pathological diagnosis that alters patient management.

Entities:  

Mesh:

Year:  2013        PMID: 24342155      PMCID: PMC3926466     

Source DB:  PubMed          Journal:  G Chir        ISSN: 0391-9005


  12 in total

1.  The incidence of non-proliferative and precancerous lesions of reduction mammoplasty: evaluation of 273 cases.

Authors:  E T Samdanci; C Firat; E Cakir; M Ak; S Sayin; Z Nurkabul
Journal:  Eur Rev Med Pharmacol Sci       Date:  2011-10       Impact factor: 3.507

2.  The price of pathology: is screening all breast reduction specimens cost effective?

Authors:  Peter F Koltz; John A Girotto
Journal:  Plast Reconstr Surg       Date:  2010-05       Impact factor: 4.730

3.  Oncological screening for Bilateral Breast Reduction: a survey of practice variations in UK Breast and Plastics surgeons 2009.

Authors:  Anusha A Hennedige; Tze Yean Kong; Ashu Gandhi
Journal:  J Plast Reconstr Aesthet Surg       Date:  2010-12-31       Impact factor: 2.740

4.  Histopathological findings in surgical specimens obtained from reduction mammaplasties.

Authors:  Giovanni Andre Pires Viana; Ivo Pitanguy; Ernani Torres
Journal:  Breast       Date:  2005-06       Impact factor: 4.380

5.  Should we be analysing breast reduction specimens? A systematic analysis of over 1,000 consecutive cases.

Authors:  Faiza E Hassan; Marc D Pacifico
Journal:  Aesthetic Plast Surg       Date:  2012-06-08       Impact factor: 2.326

6.  Occult breast carcinoma in reduction mammaplasty specimens: 14-year experience.

Authors:  Amy S Colwell; Jasleen Kukreja; Karl H Breuing; Susan Lester; Dennis P Orgill
Journal:  Plast Reconstr Surg       Date:  2004-06       Impact factor: 4.730

7.  Incidence of precancerous lesions in breast reduction tissue: a pathologic review of 562 consecutive patients.

Authors:  Clancy J Clark; Susan Whang; Keith T Paige
Journal:  Plast Reconstr Surg       Date:  2009-10       Impact factor: 4.730

8.  Does histopathological examination of breast reduction specimens affect patient management and clinical follow up?

Authors:  I S Cook; C E Fuller
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

9.  Breast reductions: what to do with all the tissue specimens?

Authors:  L Bondeson; F Linell; A Ringberg
Journal:  Histopathology       Date:  1985-03       Impact factor: 5.087

10.  Radiotherapy after conservative surgery in ductal carcinoma in situ of the breast: a review.

Authors:  Maurizio Amichetti; Cristiana Vidali
Journal:  Int J Surg Oncol       Date:  2012-05-13
View more
  1 in total

1.  Pathology Examination of Breast Reduction Specimens: Dispelling the Myth.

Authors:  Mark Fisher; Aaron L Burshtein; Joshua G Burshtein; Panagiotis Manolas; Scot B Glasberg
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-11-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.